The 2nd Ambulatory Glucose Profile (AGP) & Digital Therapeutics (DTx) Conference, held in Shenzhen, showcased the latest advancements in diabetes diagnosis and treatment. Experts from around the world gathered to discuss the application of AGP and digital therapeutics in precision medicine. The summit forum, led by Professor Ji Linong, delved into topics such as AGP consensus, the Chinese diabetes patient database, artificial pancreas system, and digital health management.
One key highlight of the conference was the acknowledgment of China’s progress in AGP clinical practice by Professor Andrej Janež from Slovenia. China has developed an AGP training program and is leveraging AI to enhance diagnosis and treatment decisions, ultimately improving diabetes care on a global scale. To further drive innovation and standardize AGP clinical applications worldwide, the International Consortium for AGP&DTx R&D was established, creating a collaborative platform for advancing diabetes management.
SIBIONICS, a company founded in 2015, is at the forefront of research and development in implantable medical devices. By integrating CGM technology with patient-centered design, SIBIONICS is revolutionizing personalized diabetes management solutions. With a user base of over 1,000,000 worldwide, SIBIONICS is recognized for its reliability and innovation in diabetes care.
The AGP&DTx Summit Forum in Shenzhen served as a catalyst for global collaboration in advancing diabetes diagnosis and treatment. By fostering partnerships and sharing knowledge, the forum aims to enhance the care of individuals with diabetes on a global scale. The establishment of the International Consortium for AGP&DTx R&D signifies a commitment to standardizing best practices and encouraging international cooperation in the field of diabetes management.
For more information on the latest developments in diabetes care and digital therapeutics, visit the official website of the National Innovation Center for Advanced Medical Devices. Stay updated on cutting-edge technologies and industry news by following the work of SIBIONICS and other key players in the field. Together, we can drive innovation and improve outcomes for individuals living with diabetes worldwide.
Source link
